EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function

Joana Santos-Gomes iD, Pedro Mendes-Ferreira, Rui Adão iD, Carolina Maia-Rocha iD, Beatriz Rego, Manu Poels, Anaïs Saint-Martin Willer iD, Bastien Masson iD, Steeve Provencher, Sébastien Bonnet iD, David Montani iD, Frédéric Perros iD und 3 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Joana Santos-Gomes und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. Hauptthemen laut MEDLINE: MicroRNAs, Pulmonary Arterial Hypertension, Pulmonary Artery, Ventricular Function, Right. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, European Union's Horizon 2020, French National Institute for Health and Medical Research (INSERM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a chronic disorder characterized by excessive pulmonary vascular remodeling, leading to elevated pulmonary vascular resistance and right ventricle (RV) overload and failure. MicroRNA-146a (miR-146a) promotes vascular smooth muscle cell proliferation and vascular neointimal hyperplasia, both hallmarks of PAH. This study aimed to investigate the effects of miR-146a through pharmacological or genetic inhibition on experimental PAH and RV pressure overload animal models. Additionally, we examined the overexpression of miR-146a on human pulmonary artery smooth muscle cells (hPASMCs). Here, we showed that miR-146a genic expression was increased in the lungs of patients with PAH and the plasma of monocrotaline (MCT) rats. Interestingly, genetic ablation of miR-146a improved RV hypertrophy and systolic pressures in Sugen 5415/hypoxia (SuHx) and pulmonary arterial banding (PAB) mice. Pharmacological inhibition of miR-146a improved RV remodeling in PAB-wild type mice and MCT rats, and enhanced exercise capacity in MCT rats. However, overexpression of miR-146a did not affect proliferation, migration, and apoptosis in control-hPASMCs. Our findings show that miR-146a may play a significant role in RV function and remodeling, representing a promising therapeutic target for RV hypertrophy and, consequently, PAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPulmonary Arterial HypertensionPulmonary ArteryVentricular Function, RightAnimalsHumansMaleMiceRatsCell ProliferationDisease Models, AnimalHypertension, PulmonaryHypertrophy, Right VentricularMonocrotalineMyocytes, Smooth MuscleRats, Sprague-DawleyVascular Remodeling

Stichwörter der Autor:innen

miR-146apulmonary arterial hypertension (PAH)right ventricular (RV) failureright ventricular (RV) hypertrophy

Substanzen

MicroRNAsMIRN146 microRNA, humanMonocrotalineMIRN146a microRNA, ratMirn146 microRNA, mouse

Autor:innen und Institutionen

  • Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
  • Paris-Porto Pulmonary Hypertension Collaborative Laboratory (3PH), UMR_S 999, INSERM, Université Paris-Saclay, 91190 Paris, France.
  • Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • CIBER Enfermedades Respiratorias (Ciberes), 28029 Madrid, Spain.
  • Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), 28007 Madrid, Spain.
  • Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital de Bicêtre, 94270 Le Kremlin-Bicêtre, France.

ORCID-Profile: Joana Santos-Gomes, Rui Adão, Carolina Maia-Rocha, Anaïs Saint-Martin Willer, Bastien Masson, Sébastien Bonnet, David Montani, Frédéric Perros, Fabrice Antigny, Adelino F Leite-Moreira, Carmen Brás-Silva

Förderung

  • Fundação para a Ciência e Tecnologia
  • European Union's Horizon 2020
  • French National Institute for Health and Medical Research (INSERM)
  • AFM-Téléthon #POCs(2023)-121503
  • Agence Nationale de la Recherche
  • ortuguese Foundation for Science and Technology (FCT)
  • IMPAcT
  • RELAX-2-PAH

Zitieren

APA

Santos-Gomes, J., Mendes-Ferreira, P., Adão, R., Maia-Rocha, C., Rego, B., Poels, M., Saint-Martin Willer, A., Masson, B., Provencher, S., Bonnet, S., Montani, D., Perros, F., Antigny, F., Leite-Moreira, A. F., & Brás-Silva, C. (2024). Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158054

Vancouver

Santos-Gomes J, Mendes-Ferreira P, Adão R, Maia-Rocha C, Rego B, Poels M, et al. Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158054

BibTeX
@article{SantosGomes2024,
  author = {Santos-Gomes, Joana and Mendes-Ferreira, Pedro and Adão, Rui and Maia-Rocha, Carolina and Rego, Beatriz and Poels, Manu and Saint-Martin Willer, Anaïs and Masson, Bastien and Provencher, Steeve and Bonnet, Sébastien and Montani, David and Perros, Frédéric and Antigny, Fabrice and Leite-Moreira, Adelino F and Brás-Silva, Carmen},
  title = {Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158054}
}
Kostenlos starten →